Tianjin Huixing Technology Development Co., Ltd. – Trademark Portfolio

Entity Type: 99

Tianjin Huixing Technology Development Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DYBLING. The owner is based in Tianjin.

Room A58, Building 44, #217, Renmin

Tianjin 301900 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DYBLING
DYBLING
Registered 2020

Trademark Classifications

Tianjin Huixing Technology Development Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Tianjin Huixing Technology Development Co., Ltd. have?

Tianjin Huixing Technology Development Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Tianjin Huixing Technology Development Co., Ltd. file in?

Tianjin Huixing Technology Development Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Tianjin Huixing Technology Development Co., Ltd.'s most well-known trademarks?

Tianjin Huixing Technology Development Co., Ltd.'s registered trademark portfolio includes well-known marks such as DYBLING. These are among 1 currently registered trademark in the portfolio.

What is Tianjin Huixing Technology Development Co., Ltd.'s trademark registration success rate?

Tianjin Huixing Technology Development Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.